OSTEOSARCOMA METASTATIC

This adverse event was reported 95 times

These drugs are most commonly taken by patients reporting OSTEOSARCOMA METASTATIC:

# Drug Count
0 CISPLATIN 26
1 METHOTREXATE SODIUM 22
2 DOXORUBICIN 20
3 METHOTREXATE 20
4 PAZOPANIB HYDROCHLORIDE 16
5 PAZOPANIB 15
6 ETOPOSIDE 14
7 REGORAFENIB 11
8 IFOSFAMIDE 10
9 IFOSFAMIDE FOR INJECTION 9
See all common drugs associated with OSTEOSARCOMA METASTATIC

OSTEOSARCOMA METASTATIC is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 EPHEDRINE SULFATE 1 0.0046
1 DEXRAZOXANE FOR INJECTION 3 0.0032
2 GLUCARPIDASE 1 0.0028
3 GRANULOCYTE COLONY STIMULATING FACTOR 3 0.0014
4 AMIFOSTINE 1 0.0012
5 DINUTUXIMAB 1 0.0012
6 REGORAFENIB 11 0.0009
7 LIDOCAINE AND PRILOCAINE 1 0.0007
8 PAZOPANIB HYDROCHLORIDE 16 0.0006
9 ETOMIDATE INJECTION 1 0.0005
See all drugs enriched for association with OSTEOSARCOMA METASTATIC